Effect of tenofovir disoproxil and telbivudine on the growth and development of infants by blocking mother-to-child transmission of hepatitis B virus

2Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Purpose: To investigate the effect of tenofovir disoproxil and telbivudine on the growth and development of infants after blocking mother-to-child transmission (MTCT) of hepatitis B virus (HBV). Methods: Seventy pregnant women with chronic hepatitis B (CHB) were recruited and allocated to tenofovir disoproxil group (n = 35) and telbivudine group (n = 35) using random number table method. Tenofovir disoproxil group was given 300 mg tenofovir disoproxil orally four times daily, while telbivudine group was given telbivudine 600 mg orally four times daily. Results: After treatment, both groups showed no significant differences in serum HBV-DNA and ALT levels before delivery and 3 months after delivery (p > 0.05). Both groups showed no remarkable differences in the incidence of hypohydramnios, cholestasis, hypothyroidism, anemia, prolonged labor, fetal distress, and placental adhesions (p > 0.05). Both groups showed no significant differences in the rates of premature rupture of membranes, preterm birth, vaginal delivery, and cesarean section (p > 0.05). Both groups showed no significant differences in neonatal sex, gestational age at birth, weight, length, and Apgar scores (p > 0.05). The differences in the positive rates of HBVsAg, HBsAb, and HBeAg at birth and at 12 months were not statistically noticeable (p > 0.05). Conclusion: Tenofovir disoproxil and telbivudine reduce HBV-DNA levels, effectively blocks MTCT, and have a similar safety profile for infants. Further investigations to confirm their safety as drugs for antiviral therapy in CHB pregnant women at 24 weeks of gestation is required.

References Powered by Scopus

World Medical Association declaration of Helsinki: Ethical principles for medical research involving human subjects

0
19966Citations
N/AReaders
Get full text

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

4462Citations
N/AReaders
Get full text

Chronic Hepatitis B infection a review

548Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Preliminary study on the relationship between recurrence and quasispecies characteristics in P region of hepatitis B virus genome of chronic hepatitis B patients treated with lamivudine

0Citations
N/AReaders
Get full text

Fetal distress and the levels of malondialdehyde (MDA): A meta-analysis

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tao, C., Hu, J., Zhang, S., Bai, X., Zhao, C., Zuo, Z., & Liu, S. (2022). Effect of tenofovir disoproxil and telbivudine on the growth and development of infants by blocking mother-to-child transmission of hepatitis B virus. Tropical Journal of Pharmaceutical Research, 21(9), 1985–1991. https://doi.org/10.4314/tjpr.v21i9.24

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Researcher 2

40%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

40%

Nursing and Health Professions 2

40%

Mathematics 1

20%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free